Glutamine preferentially inhibits T-helper type 2 cell-mediated airway inflammation and late airway hyperresponsiveness through the inhibition of cytosolic phospholipase A2 activity in a murine asthma model

Clinical and Experimental Allergy

Volumn 38, Issue 2, 2008, Pages 357-364

  Ko, H M ^b   Kang, N I ^a   Kim, Y S ^a   Lee, Y M ^a   Jin, Z W ^a   Jung, Y J ^a   Im, S Y ^b   Kim, J H ^c   Shin, Y H ^c   Cho, B H ^a   Lee, H K ^a,b  

^a Chonbuk National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

^c Korea University   (South Korea)

Author keywords

Airway hyperresponsiveness; Asthma; CPLA2; Glutamine; Th2

Indexed keywords

CYTOKINE; G 8540; GLUTAMINE; MESSENGER RNA; MUCIN; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

AIRWAY; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EOSINOPHILIA; FEMALE; HELPER CELL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INHIBITION KINETICS; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MOUSE; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT MUCOSA; SMEAR; WESTERN BLOTTING;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHITIS; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; GLUTAMINE; MICE; MICE, INBRED BALB C; MUCUS; NEUTROPHILS; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHORYLATION; TH2 CELLS;

EID: 38349118907     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02900.x     Document Type: Article

References (33)

1. Häussinger D. Hepatic Glutamine transport and metabolism. Adv Enzymol 1998 72: 43 86.
2. Fox RE, Hopkins IB, Cabacungan ET, Tildon JT. The role of glutamine and other alternate substrates as energy sources in the fetal rat lung type II cell. Pediatr Res 1996 40: 135 41.
3. Encarnacion S, Calderon J, Gelbard AS, Cooper AJ, Mora J. Glutamine biosynthesis and the utilization of succinate and glutamine by Rhizobium etli and Sinorhizobium meliloti. Microbiology 1998 144: 2629 38.
4. Kovacevic Z, McGivan JD. Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol Rev 1983 63: 547 605.
5. Newsholme EA, Crabtree B, Ardawi MSM. Glutamine metabolism in lymphocytes: its biochemical, physiological, and clinical importance. Q J Exp Physiol 1985 70: 473 89.
6. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001 16: 398 402.
7. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine supplemented parenteral nutrition. Nutrition 1997 13: 295 302.
8. Kew S, Wells SM, Yaqoob P, Wallace FA, Miles EA, Calder PC. Dietary glutamine enhances murine T-lymphocyte responsiveness. J Nutr 1999 129: 1524 31.
9. Kim YS, Kim GY, Kim JH et al. Glutamine inhibits lipopolysaccharide- induced cytoplasmic phospholipase A2 activation and protects against endotoxin shock in mouse. Shock 2006 25: 290 4.
10. 2 in allergic response and parturition. Nature 1997 390: 618 22.
11. 2-inhibition. Nat Immunol 2001 2: 145 9.
12. 2 activation. J Allergy Clin Immunol 2005 116: 537 43.
13. Fischer AR, McFadden CA, Frantz R et al. Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects. Am J Respir Crit Care Med 1995 152: 1203 7.
14. 2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 1986 133: 252 4.
15. Jones GL, Saroea HG, Watson RM, O'Byrne PM. Effect of an inhaled thromboxane mimetic (U46619) on airway function in human subjects. Am Rev Respir Dis 1992 145: 1270 4.
16. Choi IH, Kim YS, Kim DK et al. Platelet-activating factor-mediated NF-κB-dependency of a late anaphylactic reaction. J Exp Med 2003 198: 145 51.
17. Eum SY, Maghni K, Hamid Q, Campbell H, Eidelman DH, Martin JG. Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol 2003 28: 25 32.
18. Takeda K, Hamelmann E, Joetham A et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997 186: 449 54.
19. Corry DB, Rishi K, Kanellis J et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol 2002 3: 347 53.
20. Drouin SM, Corry DB, Hollman TJ, Kildsgaard J, Wetsel RA. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol 2002 169: 5926.
21. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991 87: 893.
22. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991 143: 138.
23. 4 and granulocytic infiltration into asthmatic airways. Lancet 1993 341: 989 90.
24. Pizzichini E, Leff JA, Reiss TF et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 1999 14: 12 8.
25. Parameswaran K, Liang H, Fanat A, Watson R, Snider DP, O'Byrne PM. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J Allergy Clin Immunol 2004 114: 73 9.
26. Irvin CG, Tu YP, Sheller JR, Funk CD. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am J Physiol 1997 272: L1053 8.
27. Henderson WR, Lewis JDB, Albert RK et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 1996 184: 1483 94.
28. Parry-Billings M, Evans J, Calder PC. Does glutamine contribute to immunosuppression after major burn? Lancet 1990 336: 523 5.
29. Gore DC, Jahoor F. Glutamine kinetics in burn patients comparison with hormonally induced stress in volunteers. Arch Surg 1994 129: 1318 23.
30. Newsholme EA. The possible role of glutamine in some cells of the immune system and the possible consequence for the whole animal. Experientia 1996 52: 455 9.
31. Wischmeyer PE, Lynch J, Liedel J et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 2001 29: 2075 80.
32. Ziegler TR, Young LS, Benfell K et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992 116: 821 8.
33. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002 30: 2022 9.